STOCK TITAN
  1. Home
  2. Financials
  3. TAK
  4. EPS (Diluted)

Takeda Pharmaceutical Company Limited (TAK) EPS by Year

TAK

Takeda Pharmaceutical Company Limited earned $0.45 per diluted share in fiscal year 2025. This represents a decrease of 25.6% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Takeda Pharmaceutical Company Limited has filed alongside them.

FY2025 annual
EPS (Diluted) $0.45
YoY -25.6%
5Y CAGR +11.3%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TAK EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-F
EPS (Diluted)$0.45-25.6%$0.60-60.4%$1.52+26.6%$1.20-44.4%$2.16+722.4%$0.26$1.26-43.5%$2.24+70.4%$1.31

TAK EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
EPS (Diluted)N/AN/AN/AN/AN/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Takeda Pharmaceutical Company Limited financials

Frequently Asked Questions

What was Takeda Pharmaceutical Company Limited's diluted earnings per share in fiscal year 2025?

Takeda Pharmaceutical Company Limited earned $0.45 per diluted share in fiscal year 2025.

How fast is Takeda Pharmaceutical Company Limited's diluted earnings per share growing?

Takeda Pharmaceutical Company Limited (TAK) diluted earnings per share fell by 25.6% year over year, from $0.60 to $0.45 in fiscal year 2025.

How has Takeda Pharmaceutical Company Limited's diluted earnings per share changed over the years?

Across the 9 fiscal years this page covers, Takeda Pharmaceutical Company Limited (TAK) diluted earnings per share went from $1.31 in fiscal year 2017 to $0.45 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Takeda Pharmaceutical Company Limited (TAK) reported on that line in every period on record.